SCHEMBL20159639

SCHEMBL20159639

COc1ccc(N(c2ccc3c(c2)C(C)(C)c2ccccc2-3)c2ccc3c(c2)C2(c4cc(N(c5ccc(OC)cc5)c5ccc6c(c5)C(C)(C)c5ccccc5-6)ccc4-3)c3cc(N(c4ccc(OC)cc4)c4ccc5c(c4)C(C)(C)c4ccccc4-5)ccc3-c3ccc(N(c4ccc(OC)cc4)c4ccc5c(c4)C(C)(C)c4ccccc4-5)cc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.41
PDK2 Q15119 6/20 0.41
PDE4D Q08499 1/20 0.37
ABL1 P00519 1/20 0.36
ABCB1 P08183 1/20 0.36
BCR P11274 1/20 0.36
RPS6KA2 Q15349 1/20 0.35
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
MAOA P21397 1/20 0.34
PTGS2 P35354 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GPR3 P46089 1/20 0.34
CES1 P23141 1/20 0.34
ALOX15 P16050 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16996394 0.99 PGR (0.40) PGRPDK2PDE4DABL1ABCB1
SCHEMBL15185753 0.96 PGR (0.44) PGRPDK2ABL1ABCB1BCR
SCHEMBL16996396 0.95 PDK2 (0.45) PGRPDK2PDE4DABL1ABCB1
SCHEMBL10057765 0.93 PGR (0.42) PGRPDK2ABL1ABCB1BCR
SCHEMBL17735813 0.92 PDK2 (0.49) PGRPDK2ABL1ABCB1BCR
SCHEMBL11954910 0.92 PDK2 (0.44) PGRPDK2ABL1ABCB1BCR
SCHEMBL10058152 0.92 PDK2 (0.49) PGRPDK2ABL1ABCB1BCR
SCHEMBL10057800 0.92 PDK2 (0.49) PGRPDK2ABL1ABCB1BCR
SCHEMBL29352894 0.92 PDK2 (0.44) PGRPDK2PDE4DABL1ABCB1
SCHEMBL20159380 0.92 PDK2 (0.44) PGRPDK2PDE4DABL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563180-B2 Spirobifluorene compound and perovskite solar cell comprising same KOREA RESEARCH INSTITUTE OF CHECMICAL TECHNOLOGY (KR) 2023-01-24 US disclosed
US-20190288207-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2019-09-19 US disclosed
WO-2018088797-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME 한국화학연구원 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11563180-B2 Spirobifluorene compound and perovskite solar cell comprising same SLC9B2, STOM, SLC46A1 PGR 3108/4885PDK2 332/4885PDE4D 3883/4885
US-20190288207-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME SLC9B2, STOM, SLC46A1 PGR 3108/4885PDK2 332/4885PDE4D 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.